Matthew T. David - Jan 2, 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Financial Officer
Signature: /s/ Matthew T David
Stock symbol: CRMD
Transactions as of: Jan 2, 2025
Transactions value $: -$71,087
Form type: 4
Date filed: 1/6/2025, 09:40 PM
Previous filing: Jan 17, 2024
Next filing: Jan 14, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+62.5K	+130.39%	$0.00	110K	Jan 2, 2025	Direct	F1
transaction	CRMD	Common Stock	Tax liability	-$71.1K	-8.65K	-7.83%	$8.22	102K	Jan 2, 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Content

These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.